CLINICAL_TRIALS
trial_result
· 2013-06-24
Clinical Trial Update: flt3L in Treating Patients With Acute Myeloid Leukemia [Phase 3]
Summary
Phase 3 trial evaluating FLT3 ligand (flt3L) in treating acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 3 | Status: COMPLETED